Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.71 -4.25 (-0.84%)
At close: Oct 1, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Cash from Financing Activities (2010 - 2026)

Updated

Madrigal Pharmaceuticals' Cash from Financing Activities came in at $3.11 million for Q2 2026, up 78.7% from $1.74 million a year earlier and up 33.6% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Madrigal Pharmaceuticals reported Cash from Financing Activities of $251.04 million, up 567.4% year-over-year; for FY2025, it was $255.98 million, down 65.2% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of 118.9% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $735.06 million in FY2024 (+23.5%), $595.12 million in FY2023 (+89.9%), $313.45 million in FY2022 (+83.1%) and $171.24 million in FY2021.
  • The five-year range for quarterly Cash from Financing Activities is $1.74 million (Q2 2025) to $573.71 million (Q1 2024).
  • Year-over-year, Cash from Financing Activities increased in 1 of the last seven quarters, with an average decline of 57.7%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2024 (growth of 988.8%), and the weakest in Q2 2025 (a decline of 98.7%).
  • Business Quant data shows MDGL's Cash from Financing Activities at $2.33 million (Q1 2026), $8.96 million (Q4 2025) and $236.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Madrigal Pharmaceuticals 14.69 Bn 10.94 Bn - 3.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.11 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 8.96 Mn
Sep 30, 2025 236.65 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 8.64 Mn
Dec 31, 2024 19.77 Mn
Sep 30, 2024 7.46 Mn
Jun 30, 2024 134.12 Mn
Mar 31, 2024 573.71 Mn
Dec 31, 2023 479.92 Mn
Sep 30, 2023 19.58 Mn
Jun 30, 2023 42.93 Mn
Mar 31, 2023 52.69 Mn
Dec 31, 2022 264.34 Mn
Jun 30, 2022 49.11 Mn
Dec 31, 2021 19.50 Mn
Sep 30, 2021 21.10 Mn
Jun 30, 2021 63.54 Mn
Mar 31, 2021 67.09 Mn
API Access

Madrigal Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MDGL&period=max&api_key=YOUR_API_KEY